|
Product Information |
|
Product name |
16α-Hydroxyprednisolone; 16α-Hydroxy prednisolone; 16alpha-Hydroxyprednisolone; 11a,16b,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione; budesonide intermediate; 16Α-Hydroxy-Prednisolone; Budesonide Hydrolysate; Budesonide Impurity A |
|
CAS No. |
13951-70-7 |
|
Molecular Formula |
C21H28O6 |
|
Molecular Weight |
376.45 |
|
Quality Standard |
99% up by HPLC |
|
Appearance |
White to off white crystalline powder |
|
COA |
|
ANALYSIS |
SPECIFICATION |
RESULTS |
|
Appearance |
White to off white crystalline powder |
Off white crystalline powder |
|
Solubility |
Sparingly soluble in Methanol.(0.1 g of sample in 10 ml of methanol) |
Conforms |
|
Loss on drying |
≤0.5% |
0.07% |
|
Specific optical rotation |
+71° ~ +79° |
+71.7° |
|
Relative substance (HPLC) |
1,2-Dihydronot ≤ 0.15% |
0.07% |
|
Single impurity ≤ 0.2% |
0.11% |
|
|
16α-Hydroxy prednisolone 21-acetate ≤0.10% |
ND |
|
|
Total impurity ≤1.0% |
0.18% |
|
|
Assay(HPLC) |
≥99.0% |
100.2% |
|
Conclusion |
The sample complies with the Requirements of In Enterprise Specifications. |
|
|
Usage |
16α-Hydroxyprednisolone is an intermediate in the production of glucocorticoid APIs, serving as a crucial raw material for the synthesis of approved ned-type drugs (such as triamcinolone, budesonide, ciclesonide, and desonide). Ned-type drugs belong to inhaled glucocorticoids, characterized by local application, low dosage, strong local anti-inflammatory effects, and minimal systemic side effects. They are widely used in the treatment of refractory asthma and inflammation.